Caldwell Sutter Capital, Inc. Glaukos Corp Transaction History
Caldwell Sutter Capital, Inc.
- $218 Billion
- Q2 2025
A detailed history of Caldwell Sutter Capital, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 45 shares of GKOS stock, worth $4,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 2,913
98.46%
Holding current value
$4,243
Previous $287 Million
98.38%
% of portfolio
0.0%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding GKOS
# of Institutions
359Shares Held
50.2MCall Options Held
260KPut Options Held
776K-
Black Rock Inc. New York, NY8.04MShares$758 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$563 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.29MShares$216 Million0.04% of portfolio
-
State Street Corp Boston, MA1.98MShares$187 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.94MShares$183 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.49B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...